OMGA Omega Therapeutics, Inc. - 10-K
Filed Mar 28, 2024 for fiscal period ending Dec 31, 2023. See issuer overview · financials · original on SEC.gov ↗
Accession
0000950170-24-038094Signal
Material rewritefull-docYoY shift: Lean -
Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.49pp more bearish than last year's.
Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.
Per-snippet highlights
Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
Material contracts, certifications & more
14 exhibits filed with this 10-K
- Exhibit 10.9omga-ex10_9.htm · 220.4 KB
- Exhibit 10.12omga-ex10_12.htm · 15.0 KB
- Exhibit 10.13omga-ex10_13.htm · 15.2 KB
- Exhibit 10.18omga-ex10_18.htm · 59.2 KB
- Exhibit 10.20omga-ex10_20.htm · 61.7 KB
- Exhibit 10.22omga-ex10_22.htm · 58.6 KB
- Exhibit 10.33omga-ex10_33.htm · 1.4 MB
- Exhibit 23.1: Consent of Independent Auditorsomga-ex23_1.htm · 3.7 KB
- Exhibit 31.1: Rule 13a-14(a) Certification (CEO)omga-ex31_1.htm · 16.5 KB
- Exhibit 31.2: Rule 13a-14(a) Certification (CFO)omga-ex31_2.htm · 16.5 KB
- Exhibit 32.1: Section 1350 Certification (CEO)omga-ex32_1.htm · 8.7 KB
- Exhibit 32.2: Section 1350 Certification (CFO)omga-ex32_2.htm · 8.5 KB
- Exhibit 97omga-ex97.htm · 39.5 KB
- 0000950170-24-038094-index-headers.html0000950170-24-038094-index-headers.html
- Ticker
- OMGA
- CIK
0001850838- Form Type
- 10-K
- Accession Number
0000950170-24-038094- Filed
- Mar 28, 2024
- Period
- Dec 31, 2023 (Q4 23)
- Industry
- Biological Products, (No Diagnostic Substances)
External resources
Permalink
https://insiderdelta.com/issuers/OMGA/10-k/0000950170-24-038094